These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases. Bedoya A; Glisinski K; Clarke J; Lind RN; Buckley CE; Shofer S Am J Case Rep; 2017 Jul; 18():842-846. PubMed ID: 28757601 [TBL] [Abstract][Full Text] [Related]
91. Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. Inbar R; Weiss R; Tomljenovic L; Arango MT; Deri Y; Shaw CA; Chapman J; Blank M; Shoenfeld Y Immunol Res; 2017 Feb; 65(1):136-149. PubMed ID: 27421722 [TBL] [Abstract][Full Text] [Related]
92. Metformin for the Treatment of Recurrent Respiratory Papillomatosis. Din-Lovinescu C; Blitzer A Ann Otol Rhinol Laryngol; 2023 Aug; 132(8):970-975. PubMed ID: 36131550 [TBL] [Abstract][Full Text] [Related]
93. Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population. Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF Laryngoscope; 2021 Mar; 131(3):E921-E928. PubMed ID: 33107615 [TBL] [Abstract][Full Text] [Related]
94. Stabilization of Recurrent Respiratory Papillomatosis with Pembrolizumab Therapy: A Case Report. Strohl MP; Rosen CA J Voice; 2023 Jul; 37(4):637.e1-637.e3. PubMed ID: 33992478 [TBL] [Abstract][Full Text] [Related]
95. Quality of life of young patients with recurrent respiratory papillomatosis. Montaño-Velázquez BB; Nolasco-Renero J; Parada-Bañuelos JE; Garcia-Vázquez F; Flores-Medina S; García-Romero CS; Jáuregui-Renaud K J Laryngol Otol; 2017 May; 131(5):425-428. PubMed ID: 28193306 [TBL] [Abstract][Full Text] [Related]
97. Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months. Ogilvie G; Sauvageau C; Dionne M; McNeil S; Krajden M; Money D; Dobson S JAMA; 2017 Apr; 317(16):1687-1688. PubMed ID: 28444267 [No Abstract] [Full Text] [Related]
98. Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation of Utility in a Typical Clinical Practice. Hall SR; Thiriveedi M; Yandrapalli U; Zhang N; Lott DG Ann Otol Rhinol Laryngol; 2021 Oct; 130(10):1164-1170. PubMed ID: 33648353 [TBL] [Abstract][Full Text] [Related]
99. A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination. Maor D; Brennand S; Goh MS; Fahey V; Tabrizi SN; Chong AH Australas J Dermatol; 2018 May; 59(2):147-148. PubMed ID: 28718200 [No Abstract] [Full Text] [Related]
100. MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis. Cabo Beltran OR; Rosales Ledezma R Head Neck; 2019 Mar; 41(3):657-665. PubMed ID: 30605254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]